| Year |
Citation |
Score |
| 2023 |
Shillingford JM, Shayman JA. Functional TFEB activation characterizes multiple models of renal cystic disease and loss of polycystin-1. American Journal of Physiology. Renal Physiology. PMID 36794754 DOI: 10.1152/ajprenal.00237.2022 |
0.589 |
|
| 2018 |
Weimbs T, Shillingford JM, Torres J, Kruger SL, Bourgeois BC. Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease. Clinical Kidney Journal. 11: i27-i38. PMID 30581563 DOI: 10.1093/Ckj/Sfy089 |
0.782 |
|
| 2018 |
Kipp KR, Kruger SL, Schimmel MF, Parker N, Shillingford JM, Leamon CP, Weimbs T. Comparison of folate-conjugated rapamycin versus unconjugated rapamycin in an orthologous mouse model of polycystic kidney disease. American Journal of Physiology. Renal Physiology. PMID 29717938 DOI: 10.1152/Ajprenal.00057.2018 |
0.793 |
|
| 2012 |
Shillingford JM, Leamon CP, Vlahov IR, Weimbs T. Folate-conjugated rapamycin slows progression of polycystic kidney disease. Journal of the American Society of Nephrology : Jasn. 23: 1674-81. PMID 22859856 DOI: 10.1681/Asn.2012040367 |
0.801 |
|
| 2012 |
Stayner C, Shields J, Slobbe L, Shillingford JM, Weimbs T, Eccles MR. Rapamycin-mediated suppression of renal cyst expansion in del34 Pkd1-/- mutant mouse embryos: an investigation of the feasibility of renal cyst prevention in the foetus. Nephrology (Carlton, Vic.). 17: 739-47. PMID 22725947 DOI: 10.1111/J.1440-1797.2012.01639.X |
0.781 |
|
| 2011 |
Olsan EE, Mukherjee S, Wulkersdorfer B, Shillingford JM, Giovannone AJ, Todorov G, Song X, Pei Y, Weimbs T. Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney disease. Proceedings of the National Academy of Sciences of the United States of America. 108: 18067-72. PMID 22025716 DOI: 10.1073/Pnas.1111966108 |
0.676 |
|
| 2011 |
Talbot JJ, Shillingford JM, Vasanth S, Doerr N, Mukherjee S, Kinter MT, Watnick T, Weimbs T. Polycystin-1 regulates STAT activity by a dual mechanism. Proceedings of the National Academy of Sciences of the United States of America. 108: 7985-90. PMID 21518865 DOI: 10.1073/Pnas.1103816108 |
0.682 |
|
| 2010 |
Shillingford JM, Piontek KB, Germino GG, Weimbs T. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. Journal of the American Society of Nephrology : Jasn. 21: 489-97. PMID 20075061 DOI: 10.1681/Asn.2009040421 |
0.747 |
|
| 2006 |
Shillingford JM, Murcia NS, Larson CH, Low SH, Hedgepeth R, Brown N, Flask CA, Novick AC, Goldfarb DA, Kramer-Zucker A, Walz G, Piontek KB, Germino GG, Weimbs T. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proceedings of the National Academy of Sciences of the United States of America. 103: 5466-71. PMID 16567633 DOI: 10.1073/Pnas.0509694103 |
0.81 |
|
| 2006 |
Hedgepeth RC, Goldfarb DA, Shillingford JM, Novick AC, Weimbs T. 549: The Effect of Rapamycin Immunosuppression on Native Polycystic Kidney Volumes in Renal Transplant Patients Journal of Urology. 175: 178-178. DOI: 10.1016/S0022-5347(18)32795-2 |
0.719 |
|
| 2006 |
Hedgepeth RC, Shillingford JM, Murcia NS, Larson CH, Flask CA, Flask CA, Novick AC, Goldfarb DA, Low SH, Weimbs T. 548: Inhibition of the MTOR Pathway by Rapamycin Reverses Renal Cystogenesis in Polycystic Kidney Disease Models Journal of Urology. 175: 178-178. DOI: 10.1016/S0022-5347(18)32794-0 |
0.792 |
|
| 2005 |
Fei B, Flask C, Wang H, Pi A, Wilson D, Shillingford J, Murcia N, Weimbs T, Duerk J. Image Segmentation, Registration and Visualization of Serial MR Images for Therapeutic Assessment of Polycystic Kidney Disease in Transgenic Mice. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 1: 467-9. PMID 17282217 DOI: 10.1109/IEMBS.2005.1616448 |
0.605 |
|
| Show low-probability matches. |